GRACE Score Calculator
Calculate 6-month post-ACS mortality risk using the Global Registry of Acute Coronary Events score.
Reviewed for accuracy by Rahul Singh, Health & Wellness Specialist
Medical disclaimer: This calculator is provided for educational and informational purposes only and does not constitute medical advice, diagnosis, or treatment. Results are general estimates and may not reflect your individual circumstances. Always consult a qualified healthcare professional before making decisions about your health.
GRACE Score Calculator
Calculator
Adjust values & calculateEnter your values below. Every result is computed in your browser โ no data is sent to any server.
Formula: GRACE Score = Age Points + HR Points + SBP Points + Creatinine Points + Killip Points + Arrest Points + ST Points + Enzyme Points
Worked example โ GRACE Score: 245 | Risk: HIGH | In-Hospital Mortality: >3% | Recommend urgent invasive strategy within 24h
Formula
GRACE Score = Age Points + HR Points + SBP Points + Creatinine Points + Killip Points + Arrest Points + ST Points + Enzyme Points
Each of the 8 clinical variables is converted to points using validated lookup tables derived from the GRACE registry of over 100,000 ACS patients. The total score predicts in-hospital and 6-month mortality. Scores below 108 are low risk, 109-140 are intermediate risk, and above 140 are high risk.
Worked Examples
Example 1: High-Risk NSTEMI Patient
Problem:A 75-year-old presents with NSTEMI. HR: 105, SBP: 95, Creatinine: 2.1, Killip Class III, no cardiac arrest, ST depression present, elevated troponin.
Solution:Age 75: 75 points HR 105: 15 points SBP 95: 53 points Creatinine 2.1: 21 points Killip III: 39 points Cardiac Arrest: 0 points ST Deviation: 28 points Elevated Enzymes: 14 points Total = 75+15+53+21+39+0+28+14 = 245 Risk: HIGH (>140) Estimated 6-month mortality: >8%
Result:GRACE Score: 245 | Risk: HIGH | In-Hospital Mortality: >3% | Recommend urgent invasive strategy within 24h
Example 2: Low-Risk Unstable Angina Patient
Problem:A 48-year-old with chest pain. HR: 72, SBP: 145, Creatinine: 0.9, Killip Class I, no arrest, no ST changes, normal enzymes.
Solution:Age 48: 25 points HR 72: 3 points SBP 145: 24 points Creatinine 0.9: 4 points Killip I: 0 points Cardiac Arrest: 0 points ST Deviation: 0 points Elevated Enzymes: 0 points Total = 25+3+24+4+0+0+0+0 = 56 Risk: LOW (<108) Estimated 6-month mortality: <3%
Result:GRACE Score: 56 | Risk: LOW | In-Hospital Mortality: <1% | Conservative management appropriate
Frequently Asked Questions
What is the GRACE score and when is it used in clinical practice?
The GRACE score, which stands for Global Registry of Acute Coronary Events, is a validated clinical risk stratification tool used to estimate mortality risk in patients presenting with acute coronary syndrome. It was developed from a multinational registry of over 100,000 patients and has been validated in numerous subsequent studies across diverse populations. The score helps clinicians make critical decisions about treatment intensity, including whether to pursue an invasive strategy with cardiac catheterization and potential intervention versus a conservative medical management approach. The GRACE score is recommended by major cardiology guidelines including the European Society of Cardiology and the American Heart Association for risk assessment at presentation and at discharge for both STEMI and NSTEMI patients.
What variables are included in the GRACE score calculation?
The GRACE score incorporates eight clinical variables that are readily available at patient presentation. These include age, heart rate, systolic blood pressure, serum creatinine level, Killip class for heart failure assessment, cardiac arrest at admission, ST-segment deviation on electrocardiogram, and elevated cardiac biomarkers such as troponin. Each variable receives a point value based on published scoring tables derived from the original registry data. Age and Killip class tend to contribute the most points, reflecting the strong prognostic importance of age and hemodynamic status in acute coronary syndrome outcomes. The total score ranges from 0 to approximately 372 points, with higher scores indicating greater mortality risk. The combination of these variables captures both the severity of the acute event and the overall patient vulnerability.
How do I interpret the GRACE score risk categories?
GRACE scores are divided into three risk categories that guide clinical management decisions. A low-risk score of 108 or below corresponds to an in-hospital mortality of less than 1 percent and a 6-month mortality of less than 3 percent. These patients may be candidates for conservative management with medical therapy alone. An intermediate-risk score between 109 and 140 indicates in-hospital mortality of 1 to 3 percent and 6-month mortality of 3 to 8 percent. These patients generally benefit from an early invasive strategy within 24 to 72 hours. A high-risk score above 140 indicates in-hospital mortality greater than 3 percent and 6-month mortality exceeding 8 percent. These patients typically require urgent invasive management within 24 hours to reduce mortality risk.
What is the Killip classification and how does it affect the GRACE score?
The Killip classification is a bedside assessment of heart failure severity in the setting of acute myocardial infarction. Killip Class I indicates no clinical signs of heart failure and adds zero points to the GRACE score. Class II indicates mild heart failure with pulmonary rales heard in the lower half of the lung fields, an S3 gallop heart sound, or elevated jugular venous pressure, adding 20 points. Class III indicates pulmonary edema with rales heard in more than half the lung fields, adding 39 points. Class IV indicates cardiogenic shock with systolic blood pressure below 90, signs of peripheral vasoconstriction, cyanosis, and oliguria, adding 59 points. The substantial point difference between classes makes Killip classification one of the most influential variables in the total GRACE score.
How does the GRACE score compare to the TIMI risk score?
The GRACE and TIMI scores are both used for acute coronary syndrome risk stratification, but they differ in complexity, variables, and discriminative ability. The TIMI score uses 7 simpler variables and produces a score from 0 to 7, making it easier to calculate at the bedside without a computer. However, the GRACE score has consistently demonstrated superior discriminative performance in validation studies, with a c-statistic of approximately 0.83 compared to 0.65 to 0.75 for the TIMI score. The GRACE score includes continuous variables like heart rate and blood pressure rather than binary cutoffs, which captures more clinical nuance. The GRACE score also includes creatinine and Killip class, which provide important information about renal function and hemodynamic status not captured by the TIMI score. Most current guidelines recommend the GRACE score as the preferred risk stratification tool for ACS.
Why is serum creatinine included in the GRACE score instead of other renal markers?
Serum creatinine was chosen for the GRACE score because it was the most widely available and rapidly obtainable marker of renal function at the time of patient presentation. Renal dysfunction is a powerful independent predictor of mortality in acute coronary syndrome because the kidneys play critical roles in fluid balance, electrolyte homeostasis, and drug clearance. Patients with elevated creatinine often have worse atherosclerotic disease burden, impaired hemodynamic compensation, and higher rates of bleeding complications from anticoagulation therapy. While estimated glomerular filtration rate or cystatin C might provide more precise renal function assessment, serum creatinine is universally available, requires no calculations, and has a turnaround time of under an hour in most emergency departments, making it practical for acute clinical decision-making.
Can the GRACE score be used for both STEMI and NSTEMI patients?
Yes, the GRACE score is validated for use in all forms of acute coronary syndrome including ST-elevation myocardial infarction, non-ST-elevation myocardial infarction, and unstable angina. The original GRACE registry included all ACS presentations, and the scoring system was derived from this heterogeneous population. However, the clinical application differs somewhat between STEMI and NSTEMI. In STEMI, the treatment decision for immediate reperfusion therapy is driven by the diagnosis itself rather than the risk score, so the GRACE score primarily informs prognosis rather than treatment selection. In NSTEMI and unstable angina, the GRACE score plays a more direct role in treatment decisions because it helps determine the urgency and timing of invasive management. High-risk NSTEMI patients with GRACE scores above 140 should receive early invasive assessment within 24 hours.
What are the limitations of the GRACE score in clinical practice?
Despite its strong validation, the GRACE score has several practical limitations. It requires access to serum creatinine results, which may not be immediately available in the prehospital setting or at initial emergency department triage. The score does not account for some important prognostic factors including diabetes, prior coronary disease, left ventricular function, and the specific coronary anatomy. It was developed primarily in Western populations and may have different calibration in other ethnic groups, though it has been validated in Asian and Middle Eastern cohorts. The score provides population-level risk estimates rather than individual predictions, meaning a specific patient with a given score may have a very different outcome than the statistical average. Finally, treatment advances since the original GRACE database was assembled in 1999 to 2009 have likely reduced overall mortality rates, potentially making the score overestimate risk in current practice.
How should the GRACE score influence decisions about invasive versus conservative management?
The GRACE score directly influences the timing and urgency of invasive management in NSTEMI and unstable angina according to major cardiology guidelines. Patients with high-risk GRACE scores above 140 should receive invasive coronary angiography within 24 hours because studies demonstrate significant mortality reduction with early intervention in this group. Intermediate-risk patients with scores between 109 and 140 should undergo angiography within 72 hours, allowing time for medical optimization while still benefiting from invasive assessment. Low-risk patients with scores below 109 may be managed with an initially conservative strategy, proceeding to angiography only if they develop recurrent symptoms, hemodynamic instability, or positive findings on non-invasive stress testing. The score should be integrated with other clinical factors including patient preferences, comorbidities, and bleeding risk rather than used as the sole decision criterion.
How is the GRACE score used for discharge planning and long-term risk assessment?
The GRACE score calculated at discharge provides valuable 6-month and 1-year mortality risk estimates that guide post-discharge management intensity. High-risk patients at discharge should receive aggressive secondary prevention including dual antiplatelet therapy, high-intensity statin therapy, beta-blockers, ACE inhibitors, and enrollment in cardiac rehabilitation programs. They also benefit from close follow-up within one to two weeks of discharge. The 6-month mortality estimate helps frame conversations with patients and families about prognosis and treatment expectations. Some institutions use discharge GRACE scores to determine the intensity of post-discharge monitoring, with high-risk patients receiving more frequent clinic visits, closer medication titration, and earlier follow-up stress testing or imaging. The GRACE score can also be recalculated at follow-up visits to track whether interventions have shifted the patient into a lower risk category.
References
Background & Theory
History
Reviewed for accuracy by Rahul Singh, Health & Wellness Specialist ยท Editorial policy
Related Calculators
๐งฎChads2 Score Calculator
Calculate the CHADS2 stroke risk score for patients with non-valvular atrial fibrillation.
๐งฎCha2ds2-Vasc Score Calculator
Calculate CHA2DS2-VASc score for stroke risk stratification in atrial fibrillation patients.
๐งฎHas-Bled Score Calculator
Assess bleeding risk in patients on anticoagulation using the HAS-BLED scoring system.
๐งฎHEART Score Calculator for Chest Pain Risk
Risk-stratify emergency department patients with chest pain using the HEART score.
๐งฎTIMI Risk Score Calculator
Calculate the TIMI risk score for STEMI and UA/NSTEMI patients.
๐งฎWells Score Dvt Calculator
Estimate pre-test probability of deep vein thrombosis using the Wells clinical criteria.
๐งฎWells Score PE Calculator
Estimate pre-test probability of pulmonary embolism using the Wells criteria.
๐งฎFramingham Risk Score Calculator
Calculate 10-year cardiovascular disease risk using the Framingham risk assessment model.